CLINICAL_TRIALS
trial_result
· 2020-04-29
Clinical Trial Update: Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma [NA]
Summary
Clinical trial of PSMA-targeted 18F-DCFPyL PET/CT in evaluating renal cell carcinoma has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johns Hopkins University | Conditions: Renal Cell Carcinoma, Kidney Cancer | NA | Status: COMPLETED | Results posted: 2020-04-29